Rosty Raykov - Nov 3, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Rostislav Roykov
Stock symbol
FENC
Transactions as of
Nov 3, 2023
Transactions value $
$0
Form type
4
Date filed
11/3/2023, 05:19 PM
Previous filing
Apr 3, 2023
Next filing
Nov 9, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $119K +74.8K +32.12% $1.59* 308K Nov 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Option Contract Options Exercise -$119K -74.8K -4.48% $1.59* 1.6M Nov 3, 2023 Options 74.8K $1.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with a strike price of $1.59 and an expiration date of January 24, 2024.
F2 Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.